Lekha T, Thomas Rosina, Giridhar Anantharaman, Gopalakrishnan Mahesh
Department of Retina, Giridhar Eye Institute, Kochi, Kerala, India.
Oman J Ophthalmol. 2022 Jun 29;15(2):234-236. doi: 10.4103/ojo.ojo_226_21. eCollection 2022 May-Aug.
Thromboembolic complications are being increasingly reported in patients with COVID-19 due to the associated hypercoagulability and are an important cause for morbidity and mortality. Retinal vascular occlusions especially arterial occlusions are one of the gravest ocular complications reported. This complication may occur in severe cases with cytokine storm or even in mild or asymptomatic patients and presentation can be anytime from few days to weeks after the onset of symptoms. Ophthalmologists should be aware of this new etiology when dealing with patients having features of retinal vascular occlusions and should investigate for the same in this pandemic situation. Although reverse transcriptase polymerase chain reaction is the diagnostic test for COVID-19, serological assays have a role in patients with delayed presentation. We describe the clinical features and multimodal imaging findings in a patient who presented with features of central retinal artery occlusion with cilioretinal artery sparing wherein his ophthalmic condition led to the diagnosis of previously undetected COVID-19 through serology. To the best of our knowledge, this is the first documentation of a case of isolated central retinal artery occlusion leading to a retrospective diagnosis of COVID-19.
由于新冠病毒感染相关的高凝状态,血栓栓塞并发症在新冠患者中报告得越来越多,是发病和死亡的重要原因。视网膜血管阻塞尤其是动脉阻塞是报告的最严重的眼部并发症之一。这种并发症可能发生在细胞因子风暴的重症病例中,甚至在轻症或无症状患者中也可能出现,症状出现后几天到几周内都可能出现。眼科医生在处理有视网膜血管阻塞特征的患者时应意识到这种新病因,并在当前大流行情况下对此进行调查。虽然逆转录聚合酶链反应是新冠病毒的诊断检测方法,但血清学检测在延迟就诊的患者中也有作用。我们描述了一名表现为视网膜中央动脉阻塞伴睫状视网膜动脉保留特征的患者的临床特征和多模态影像学表现,其眼科病情通过血清学诊断出先前未被发现的新冠病毒感染。据我们所知,这是首例孤立性视网膜中央动脉阻塞导致新冠病毒感染回顾性诊断的病例记录。